KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04640532 |
|
Recruitment Status :
Recruiting
First Posted : November 23, 2020
Last Update Posted : May 9, 2022
|
Sponsor:
Kartos Therapeutics, Inc.
Collaborator:
Telios Pharma, Inc.
Information provided by (Responsible Party):
Kartos Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 11, 2022 |
| Estimated Study Completion Date : | July 24, 2025 |